STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Recursion (NASDAQ: RXRX) ex-director plans 26,806-share sale, partly for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RECURSION PHARMACEUTICALS, INC. (RXRX) is the issuer of Class A common stock for which Christopher C. Gibson, a former director, has filed a Rule 144 notice. The filing covers the proposed sale of 26,806 Class A shares, originating from restricted stock vesting on 08/17/2026, with part of the sale intended to cover a tax obligation from a vested equity award distribution. The notice also lists extensive Class A share sales during the prior three months by Gibson, Lahwran-3 LLC, and the Gibson Family Trust.

Positive

  • None.

Negative

  • None.
Shares to be sold 26,806 shares Class A shares covered by the Rule 144 notice
Aggregate market value of shares to be sold $80,399.24 Value associated with the 26,806 Class A shares in the notice
Vesting date of underlying restricted stock 08/17/2026 Restricted Stock Vesting date for the shares to be sold
Large prior sale on 06/18/2026 340,440 shares for $1,089,541.29 Class A sale by Christopher C. Gibson disclosed as a past 3‑month transaction
Prior sale on 07/07/2026 by Lahwran-3 LLC 100,000 shares for $390,028.63 Class A sale by Lahwran-3 LLC, an account associated with Gibson
Prior sale on 07/07/2026 by Gibson Family Trust 50,000 shares for $195,014.41 Class A sale by the Gibson Family Trust, where Gibson is trustee
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Class A | 08/17/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
vested equity award distribution financial
"tax obligation resulting from the settlement of a vested equity award distribution."
attorney-in-fact regulatory
"as attorney-in-fact for Christopher C. Gibson."
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing mean for RECURSION PHARMACEUTICALS, INC. (RXRX)?
The filing discloses that a former director, Christopher C. Gibson, intends to sell 26,806 Class A shares under Rule 144. It is a notice of a potential resale by an affiliate, not an issuance of new shares by the company.

How many RXRX shares are proposed to be sold in this Form 144?
The notice covers a proposed sale of 26,806 Class A common shares of RECURSION PHARMACEUTICALS, INC. These shares are tied to a restricted stock vesting event that occurred on 08/17/2026 and are being sold through a brokerage account.

What is the reported market value of the RXRX shares covered by this Form 144?
The filing lists an aggregate market value of approximately $80,399.24 for the 26,806 Class A shares covered by the notice. This figure reflects the value used for the Rule 144 disclosure at the time of the filing.

Why does the Form 144 mention tax obligations for RXRX shares?
The remarks state that today’s sale includes an amount necessary to cover a tax obligation from the settlement of a vested equity award distribution. This indicates part of the proposed sale is linked to taxes arising from equity compensation.

What RXRX share sales in the past 3 months are disclosed in this Form 144?
The filing lists multiple Class A share sales by Christopher C. Gibson and related accounts over roughly three months, including a transaction of 340,440 shares for $1,089,541.29 on 06/18/2026 and several additional trades between late May and mid-August 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR